Evolent Health Inc Class A (EVH) financials
Evolent Health revenue and earnings by year
Evolent Health's revenue was $1.88 billion in the fiscal year to December 31, 2025, down 26.6% from the year before. Net income was -$535 million, -28.5% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 24.9% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.88 | 2.55 | 1.96 | 1.35 | 0.91 | 0.92 | 0.69 | 0.63 | 0.43 | 0.25 |
| Revenue growth | -26.6% | 30.1% | 45.3% | 48.9% | -1.8% | 34.6% | 9.6% | 44.2% | 71.1% | — |
| Gross profit | 0.40 | 0.37 | 0.46 | 0.32 | 0.25 | 0.23 | 0.17 | 0.23 | 0.17 | 0.10 |
| Gross margin | 21.3% | 14.4% | 23.4% | 23.4% | 27.6% | 24.7% | 25.3% | 36.4% | 38.1% | 39.0% |
| Operating income | -0.40 | -0.04 | -0.05 | -0.02 | -0.03 | -0.26 | -0.31 | -0.05 | -0.07 | -0.24 |
| Operating margin | -21.5% | -1.4% | -2.7% | -1.5% | -3.2% | -28.0% | -45.0% | -7.6% | -16.7% | -93.4% |
| Net income | -0.53 | -0.06 | -0.11 | -0.02 | -0.04 | -0.33 | -0.30 | -0.05 | -0.06 | -0.16 |
| Net margin | -28.5% | -2.4% | -5.8% | -1.4% | -4.1% | -36.1% | -43.9% | -8.4% | -13.9% | -62.8% |
| Diluted EPS | -$5.15 | -$0.82 | -$1.27 | -$0.20 | -$0.44 | -$3.94 | -$3.67 | -$0.68 | -$0.98 | -$3.70 |
| Free cash flow | -0.02 | -0.01 | 0.11 | -0.05 | 0.01 | -0.05 | -0.08 | -0.06 | -0.06 | -0.05 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open EVH in Markets.
See also: EVH returns
No forecast, no recommendation. This page describes Evolent Health Inc Class A from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.